Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 56

1.

Activation of PPARbeta/delta causes a psoriasis-like skin disease in vivo.

Romanowska M, Reilly L, Palmer CN, Gustafsson MC, Foerster J.

PLoS One. 2010 Mar 16;5(3):e9701. doi: 10.1371/journal.pone.0009701.

PMID:
20300524
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents.

Sharma SV, Haber DA, Settleman J.

Nat Rev Cancer. 2010 Apr;10(4):241-53. doi: 10.1038/nrc2820. Epub 2010 Mar 19. Review.

PMID:
20300105
[PubMed - indexed for MEDLINE]
3.

Polo-like kinase 1 (Plk1) as a novel drug target in chronic myeloid leukemia: overriding imatinib resistance with the Plk1 inhibitor BI 2536.

Gleixner KV, Ferenc V, Peter B, Gruze A, Meyer RA, Hadzijusufovic E, Cerny-Reiterer S, Mayerhofer M, Pickl WF, Sillaber C, Valent P.

Cancer Res. 2010 Feb 15;70(4):1513-23. doi: 10.1158/0008-5472.CAN-09-2181. Epub 2010 Feb 9.

PMID:
20145140
[PubMed - indexed for MEDLINE]
Free Article
4.

Gene expression profiling in head and neck squamous cell carcinoma.

Braakhuis BJ, Brakenhoff RH, Leemans CR.

Curr Opin Otolaryngol Head Neck Surg. 2010 Apr;18(2):67-71. doi: 10.1097/MOO.0b013e32833693ce. Review.

PMID:
20084003
[PubMed - indexed for MEDLINE]
5.

Targeting Polo-like kinase in cancer therapy.

Degenhardt Y, Lampkin T.

Clin Cancer Res. 2010 Jan 15;16(2):384-9. doi: 10.1158/1078-0432.CCR-09-1380. Epub 2010 Jan 12. Review.

PMID:
20068088
[PubMed - indexed for MEDLINE]
Free Article
6.

Molecular mechanisms of cardiovascular toxicity of targeted cancer therapeutics.

Cheng H, Force T.

Circ Res. 2010 Jan 8;106(1):21-34. doi: 10.1161/CIRCRESAHA.109.206920. Review.

PMID:
20056943
[PubMed - indexed for MEDLINE]
Free Article
7.

C20orf20 (MRG-binding protein) as a potential therapeutic target for colorectal cancer.

Yamaguchi K, Sakai M, Shimokawa T, Yamada Y, Nakamura Y, Furukawa Y.

Br J Cancer. 2010 Jan 19;102(2):325-31. doi: 10.1038/sj.bjc.6605500. Epub 2010 Jan 5.

PMID:
20051959
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Systematic comparison of nonmelanoma skin cancer microarray datasets reveals lack of consensus genes.

Van Haren R, Feldman D, Sinha AA.

Br J Dermatol. 2009 Dec;161(6):1278-87. doi: 10.1111/j.1365-2133.2009.09338.x. Epub 2009 Jun 11.

PMID:
19681882
[PubMed - indexed for MEDLINE]
9.

Polo-like kinase 1 (Plk1) in non-melanoma skin cancers.

Schmit TL, Zhong W, Nihal M, Ahmad N.

Cell Cycle. 2009 Sep 1;8(17):2697-702. Epub 2009 Sep 2.

PMID:
19652546
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Targeted depletion of Polo-like kinase (Plk) 1 through lentiviral shRNA or a small-molecule inhibitor causes mitotic catastrophe and induction of apoptosis in human melanoma cells.

Schmit TL, Zhong W, Setaluri V, Spiegelman VS, Ahmad N.

J Invest Dermatol. 2009 Dec;129(12):2843-53. doi: 10.1038/jid.2009.172. Epub 2009 Jun 25.

PMID:
19554017
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.

Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, Mortimer P, Swaisland H, Lau A, O'Connor MJ, Ashworth A, Carmichael J, Kaye SB, Schellens JH, de Bono JS.

N Engl J Med. 2009 Jul 9;361(2):123-34. doi: 10.1056/NEJMoa0900212. Epub 2009 Jun 24.

PMID:
19553641
[PubMed - indexed for MEDLINE]
Free Article
12.

The activated NF-kappaB-Snail-RKIP circuitry in cancer regulates both the metastatic cascade and resistance to apoptosis by cytotoxic drugs.

Wu K, Bonavida B.

Crit Rev Immunol. 2009;29(3):241-54. Review.

PMID:
19538137
[PubMed - indexed for MEDLINE]
13.

Polo-like kinase (PLK) inhibitors in preclinical and early clinical development in oncology.

Schöffski P.

Oncologist. 2009 Jun;14(6):559-70. doi: 10.1634/theoncologist.2009-0010. Epub 2009 May 27. Review.

PMID:
19474163
[PubMed - indexed for MEDLINE]
Free Article
14.

Single nucleotide polymorphism array analysis defines a specific genetic fingerprint for well-differentiated cutaneous SCCs.

Purdie KJ, Harwood CA, Gulati A, Chaplin T, Lambert SR, Cerio R, Kelly GP, Cazier JB, Young BD, Leigh IM, Proby CM.

J Invest Dermatol. 2009 Jun;129(6):1562-8. doi: 10.1038/jid.2008.408. Epub 2009 Jan 8.

PMID:
19131950
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006.

Fine JD, Johnson LB, Weiner M, Li KP, Suchindran C.

J Am Acad Dermatol. 2009 Feb;60(2):203-11. doi: 10.1016/j.jaad.2008.09.035. Epub 2008 Nov 20.

PMID:
19026465
[PubMed - indexed for MEDLINE]
16.

Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression.

Carvalho B, Postma C, Mongera S, Hopmans E, Diskin S, van de Wiel MA, van Criekinge W, Thas O, Matthäi A, Cuesta MA, Terhaar Sive Droste JS, Craanen M, Schröck E, Ylstra B, Meijer GA.

Gut. 2009 Jan;58(1):79-89. doi: 10.1136/gut.2007.143065. Epub 2008 Oct 1.

PMID:
18829976
[PubMed - indexed for MEDLINE]
17.

Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression.

Scotto L, Narayan G, Nandula SV, Arias-Pulido H, Subramaniyam S, Schneider A, Kaufmann AM, Wright JD, Pothuri B, Mansukhani M, Murty VV.

Genes Chromosomes Cancer. 2008 Sep;47(9):755-65. doi: 10.1002/gcc.20577.

PMID:
18506748
[PubMed - indexed for MEDLINE]
18.

The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis.

Riker AI, Enkemann SA, Fodstad O, Liu S, Ren S, Morris C, Xi Y, Howell P, Metge B, Samant RS, Shevde LA, Li W, Eschrich S, Daud A, Ju J, Matta J.

BMC Med Genomics. 2008 Apr 28;1:13. doi: 10.1186/1755-8794-1-13.

PMID:
18442402
[PubMed]
Free PMC Article
19.

Regulation of mitosis via mitotic kinases: new opportunities for cancer management.

Schmit TL, Ahmad N.

Mol Cancer Ther. 2007 Jul;6(7):1920-31. Review.

PMID:
17620424
[PubMed - indexed for MEDLINE]
Free Article
20.

RBP2 is an MRG15 complex component and down-regulates intragenic histone H3 lysine 4 methylation.

Hayakawa T, Ohtani Y, Hayakawa N, Shinmyozu K, Saito M, Ishikawa F, Nakayama J.

Genes Cells. 2007 Jun;12(6):811-26.

PMID:
17573780
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk